loadpatents
name:-0.0096580982208252
name:-0.0075280666351318
name:-0.0016272068023682
Singhaus, Jr.; Robert R. Patent Filings

Singhaus, Jr.; Robert R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Singhaus, Jr.; Robert R..The latest application filed is for "amino-quinolines as kinase inhibitors".

Company Profile
1.9.9
  • Singhaus, Jr.; Robert R. - Collegeville PA
  • Singhaus, Jr.; Robert R. - Pottstown PA
  • Singhaus, Jr.; Robert R. - Blandon PA
  • Singhaus, Jr.; Robert R. - Norristown PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Amino-quinolines as kinase inhibitors
Grant 10,220,030 - Bury , et al.
2019-03-05
Amino quinazolines as kinase inhibitors
Grant 9,994,529 - Bury , et al. June 12, 2
2018-06-12
Amino-quinolines As Kinase Inhibitors
App 20180085365 - BURY; Michael Jonathan ;   et al.
2018-03-29
Amino Quinazolines As Kinase Inhibitors
App 20170152233 - BURY; Michael Jonathan ;   et al.
2017-06-01
Amino-quinolines As Kinase Inhibitors
App 20170128437 - BURY; Michael Jonathan ;   et al.
2017-05-11
Amino quinazolines as kinase inhibitors
Grant 9,604,938 - Bury , et al. March 28, 2
2017-03-28
Amino-quinolines as kinase inhibitors
Grant 9,604,963 - Bury , et al. March 28, 2
2017-03-28
Quinolyl Amines As Kinase Inhibitors
App 20160060249 - CASILLAS; Linda N. ;   et al.
2016-03-03
Quinolyl Amines As Kinase Inhibitors
App 20140256949 - CASILLAS; Linda N. ;   et al.
2014-09-11
Amino Quinazolines As Kinase Inhibitors
App 20140206688 - Bury; Michael Jonathan ;   et al.
2014-07-24
Amino-quinolines As Kinase Inhibitors
App 20130345258 - Bury; Michael Jonathan ;   et al.
2013-12-26
Quinolines and pharmaceutical compositions thereof
Grant 7,576,215 - Collini , et al. August 18, 2
2009-08-18
Substituted 2-phenyl benzofurans as estrogenic agents
Grant 7,022,733 - Miller , et al. April 4, 2
2006-04-04
Substituted 2-phenyl benzofurans as estrogenic agents
Grant 6,774,248 - Miller , et al. August 10, 2
2004-08-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed